Interest rate exposure remained unchanged quarter-over-quarter while credit spread exposure was notably reduced as profits were realized and short-term value dynamics argued for a more cautious approach. Geographically, the portfolio decreased non-North American domiciled exposures in favour of adding to attractive deals in the domestic market. Sector-wise, TMT-related and healthcare issuers were trimmed, while financial and dynamic hedging exposures increased.
In terms of credit quality, the portfolio reduced BBB rated and BB rated positions in favor of A rated issuers, and the portfolio ended the period with a net short exposure to high yield. We believe the Strategy is well positioned to continue to navigate ever-changing markets and generate strong risk-adjusted returns, given its expanded toolkit and commonsense approach to managing market exposures.